Private Policy
© 2024
Sustained Delivery prolongs the release of a therapeutic which can result in increased exposure and potency of a given target molecule. Advances in the design of biomaterials, such as hydrogels, microspheres, implants and nanoparticles, have contributed to the precise delivery of this therapeutic modality revolutionizing how patients are treated for many acute and chronic conditions.
Genie Biotech’s proprietary conjugation technology allows Researchers to fine tune a drug’s release in a highly controlled, novel manner. Not only are target molecules site-specifically bound to a matrix of your choosing, but the conjugate bond can also be tuned to reverse thus releasing the native molecule.
MECHANISM
Target molecules can be rapidly installed on a selected matrix under mild conditions, preserving the biological function of your therapeutic.
You can then fine tune the reversibility by controlling the rate at which the conjugate bond hydrolyzes to release your native biologic from the matrix.
1) Using FDA approved additives
2) Modifying N-terminal sequence
Private Policy
© 2024
Site-specific chemistries,
payloads & ready-made
conjugates
Explore our bioconjugation toolbox and Purchase off-the-shelf products developed for your early stage research.